SoftBank leads $1.2 billion investment in diagnostics firm Invitae

(Reuters) – A group of investors including SoftBank Group Corp will invest $1.15 billion in Invitae Corp, the U.S. genetic diagnostics company said on Monday.

(Reporting by Amruta Khandekar in Bengaluru; Editing by Shinjini Ganguli)